CRISPR Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Oncology DayGlobeNewsWire • 02/05/21
CRISPR Therapeutics Announces the Appointment of Philippe Drouet as Chief Commercial OfficerGlobeNewsWire • 02/01/21
CRISPR, Editas, Intellia: Gene Editing Stocks To Play The Next Revolution In MedicineForbes • 01/11/21
Genetics Stocks Pop After Intellia Offers Update For Gene-Editing DrugsInvestors Business Daily • 01/07/21
Move Over, Warren Buffett: This Is the Star Investor You Should Be FollowingThe Motley Fool • 12/31/20
Why CRISPR Therapeutics, Editas Medicine, and Intellia Therapeutics Stocks Are Sinking TodayThe Motley Fool • 12/29/20